Ipr Pharmaceuticals Revenue, Growth & Competitor Profile

DBA IPR PHARMACEUTICAL INC
DBA PHARMACEUTICAL MANUFACTURING

Company Profile & Annual Report for Ipr Pharmaceuticals

Access the complete profile.

Ipr Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	San Isidro Industrial Park Carr 188 Lot 17 Canovanas, PR 00729

Note: Revenues for privately held companies are statistical evaluations.


Ipr Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ipr Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Ipr Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Ipr Pharmaceuticals Annual Revenue and Growth Rate

Ipr Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ipr Pharmaceuticals's revenues are gauged from an analysis of company filings.

Ipr Pharmaceuticals's Income Statement (based on Industry Averages)

Ipr Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Ipr Pharmaceuticals is developing and marketing. Ipr Pharmaceuticals doesn't have any recent trademark applications, indicating Ipr Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ZOMIG NASAL SPRAY Pharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system [, the peripheral nervous system and urological system; pharmaceutical preparations and substances for pain and inflammation control and anaesthesia ]	07/16/2002

See all trademarks and details in the Full Report.

Market Share of Ipr Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ipr Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Ipr Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BECTON DICKINSON CARIBE	Juncos, PR	100
MSD INTERNATIONAL GMBH PUERTO RICO BRANCH	Las Piedras, PR	24
AURO PR	Caguas, PR	10
IPR PHARMACEUTICALS	Canovanas, PR	6
GALEPHAR PHARMACEUTICAL RESEARCH	Humacao, PR	5
TEVA PUERTO RICO	Fajardo, PR	4

Future Competition: Ipr Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Ipr Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)